Andrea Schmitt
Berend Malchow
Alkomiet Hasan
Peter Falkai1- 1Department of Psychiatry and Psychotherapy, LMU Munich, Munich, Germany
- 2Laboratory of Neuroscience (LIM27), Institute of Psychiatry, University of Sao Paulo, São Paulo, Brazil
During the last decades, schizophrenia has been regarded as a developmental disorder. The neurodevelopmental hypothesis proposes schizophrenia to be related to genetic and environmental factors leading to abnormal brain development during the pre- or postnatal period. First disease symptoms appear in early adulthood during the synaptic pruning and myelination process. Meta-analyses of structural MRI studies revealing hippocampal volume deficits in first-episode patients and in the longitudinal disease course confirm this hypothesis. Apart from the influence of risk genes in severe psychiatric disorders, environmental factors may also impact brain development during the perinatal period. Several environmental factors such as antenatal maternal virus infections, obstetric complications entailing hypoxia as common factor or stress during neurodevelopment have been identified to play a role in schizophrenia and bipolar disorder, possibly contributing to smaller hippocampal volumes. In major depression, psychosocial stress during the perinatal period or in adulthood is an important trigger. In animal studies, chronic stress or repeated administration of glucocorticoids have been shown to induce degeneration of glucocorticoid-sensitive hippocampal neurons and may contribute to the pathophysiology of affective disorders. Epigenetic mechanisms altering the chromatin structure such as histone acetylation and DNA methylation may mediate effects of environmental factors to transcriptional regulation of specific genes and be a prominent factor in gene-environmental interaction. In animal models, gene-environmental interaction should be investigated more intensely to unravel pathophysiological mechanisms. These findings may lead to new therapeutic strategies influencing epigenetic targets in severe psychiatric disorders.
Introduction
Schizophrenia is a severe mental disorder starting at young adulthood (Kendler et al., 1996) with a prevalence of about 1% (Jablensky, 1995; McGrath et al., 2008). Each patient suffers from an individual combination of positive, negative, and affective symptoms as well as cognitive deficits, while the severity of these symptoms can change over time depending on the disease stage. Schizophrenia is characterized by prodromal phases with rather unspecific negative and cognitive symptoms, followed by the acute illness with prevailing positive symptoms (Falkai et al., 2011). Remission of psychosis is often incomplete with negative symptoms or even persisting positive symptoms being present in 30% of the sufferers (Hasan et al., 2012) and increasing to 60% in consideration of functionality (Gaebel et al., 2006). Positive symptoms consist of mainly acoustic hallucinations, delusions, disorganized speech, and disorganized behavior as well as thought disorder. The negative symptoms comprise blunted affect, avolition, anhedonia, asociality, and alogia (Crow, 1980; Andreasen et al., 1995). Apart from affective symptoms (e.g., anxiety, depressive mood, and suicidality), another domain refers to cognitive deficits with diminished episodic memory, executive function, and attention (Hoff et al., 1996, 2005; Heinrichs and Zakzanis, 1998; Albus et al., 2002, 2006), which represent a core feature of the disease and are main predictors for poor social-functioning outcome (Green, 1996).
Affective disorders, including major depressive disorder and bipolar disorder with manic episodes, belong to the most prevalent psychiatric diseases. Being among the severe psychiatric diseases (Alsuwaidan et al., 2009), Major depressive disorder has a lifetime prevalence between 16 and 20% (Williams et al., 2007) while lifetime prevalence of bipolar disorder is around 3% in the general population (Merikangas et al., 2007). According to DSM-IV (American Psychiatric Association, 1994) symptoms include loss of energy, social withdrawal, and melancholia in depressive episodes of both major depression and bipolar disorder, and elation, irritability, increased energy with hyperactivity, racing thoughts, pressured rapid speech, decreased need for sleep and an increased involvement of pleasured activities in manic episodes of bipolar disorder. In bipolar disorder, instability of mood is one of the core symptoms, whereas melancholia is the most common sign of depressive episodes (Meyer and Hautzinger, 2003). Furthermore, apart from affective symptoms, both types of affective disorders display impaired cognitive performance, mainly in attention, memory, and executive tasks (Torres et al., 2007). However, because of the individuality of patient's symptoms, current psychiatric diagnostic manuals are not always valid and major psychiatric disorders like schizophrenia, bipolar disorder, and depression are considered as a continuum with different severity of cognitive deficits as common trait (Hill et al., 2013).
In schizophrenia, twin studies show a heritability of about 60–80% (Sullivan et al., 2003), whereas in bipolar disorder and major depression heritability has been estimated to be 6–80 and 32%, respectively (Wray and Gottesman, 2012). Genome-wide association studies (GWAS) revealed a multitude of genetic risk variants (single nucleotide polymorphisms, SNP) with low effect (Schwab and Wildenauer, 2013). New risk SNPs with high significance are located in genes for Zinc finger protein (ZNF804a), transcription factor 4 (TCF4), micro-RNA 137 (Mir137), the L-type voltage-gated calcium channel (CACNA1C), and CACNB2, Inter-alpha globulin inhibitor H3 and H5 (ITIH3-ITIH4) as well as ankyrin3 (Ank3) with mostly unknown neurobiological consequences (Schwab and Wildenauer, 2013). Ank3 and CACNA1C are also relevant for bipolar disorder (Ferreira et al., 2008) and CACNB2 has been found to be associated with schizophrenia, bipolar disorder and major depression (Cross-Disorder Group of the Psychiatric Genomics Consortium et al., 2013). In a new GWAS study, Ripke et al. (2013) estimated that in schizophrenia about 8.300 SNPs contribute to a common risk of 32%, suggesting that environmental factors interacting with the genetic background contribute to the pathophysiology (Manolio et al., 2009). In schizophrenia, environmental factors are proposed to play a role up to 60% (Benros et al., 2011) (Figure 1).
Figure 1. Interacting risk genes and environmental factors contribute to increase the risk of schizophrenia. The figure shows the estimated heritability risk to develop schizophrenia as a factor of grade of next of kin. The right side illustrates the contribution of different environmental factors such as infections, obstetric complications, stress periods, and cannabis abuse.
Neurodevelopment and Psychiatric Disorders
During the last decades, schizophrenia has been regarded as a neurodevelopmental disorder. Defective genes and environmental factors may interact to induce symptoms of the disease. The so-called “neurodevelopmental hypothesis” proposes schizophrenia to be related to adverse conditions leading to abnormal brain development during the perinatal period, whereas symptoms of the disease appear in early adulthood after the synaptic pruning process (Weinberger, 1996). In the “two-hit” model, early perinatal insults (genetic background and/or environmental factors) may lead to dysfunction of neuronal circuits and vulnerability to the disease, while a second “hit” during a critical brain development period in adolescence may induce the onset of the disease (Keshavan and Hogarty, 1999). The early perinatal period has been shown to be critical for proper brain development and more specifically the late first and second trimester have been implicated in the pathophysiology of the disease (Fatemi and Folsom, 2009). During adolescence, a synaptic pruning process with excessive elimination of synapses and loss of synaptic plasticity may lead to exacerbation of symptoms in the predisposed brain (Keshavan and Hogarty, 1999; Schmitt et al., 2011a). Additionally, myelination of the heteromodal association cortex like the prefrontal cortex occur during this period (Peters et al., 2012) and decreased fractional anisotropy which corresponds to deficits in myelination has consistently been reported in schizophrenia, suggesting disturbances in fronto-limbic connections (Yao et al., 2013). The prefrontal cortex is highly connected with the hippocampus and this neuronal network has been shown to be disturbed in schizophrenia, mainly due to neurodevelopmental disturbances (Bullmore et al., 1997; Peters et al., 2012; Rapoport et al., 2012). Accordingly, in animal models, perinatal hippocampal lesions induced dysfunction of the prefrontal cortex in adulthood (Lipska, 2004). The disconnection of the hippocampus during brain development alters prefrontal cortical circuitry, function and neurocognition such as prepulse inhibition of acoustic startle response and represents a potent neurodevelopmental animal model for schizophrenia.
Meta-analyses of structural magnetic resonance imaging studies revealed decreased hippocampal volumes and increased ventricles in first-episode schizophrenia patients, confirming the presence of neuropathology before diagnosis is possible (Steen et al., 2006; Vita et al., 2006; Adriano et al., 2012). Even in patients with ultrahigh risk to develop schizophrenia, diminished gray matter of prefrontal and hippocampal regions has been detected compared to healthy controls and in patients experiencing later transition to schizophrenia these volume deficits were yet more pronounced (Witthaus et al., 2009, 2010; Wood et al., 2010). In a comparative analysis, both schizophrenia patients and patients with treatment-resistant major depressive disorder exhibited reduced hippocampal volumes (Maller et al., 2012). Reduced hippocampal volume has also been confirmed in patients with recurrent and chronic depression (Cole et al., 2011). Shape analysis revealed deformations in subfields in the tail of the right hippocampus as well as bilateral volume reductions in patients with first-episode depression (Cole et al., 2010; Meisenzahl et al., 2010), while during the course of the disease further reductions have only been detected in schizophrenia. The presence of alterations in first-episode depression is consistent with a neurodevelopmental hypothesis of early stress experience, especially since the hippocampus plays a major role in inhibiting stress response (McEwen and Magarinos, 2001), providing inhibitory feedback to the hypothalamic-pituitary-adrenal (HPA) axis (Fanselow, 2000).
Stress During Neurodevelopment
Potential stress-inducing factors are migration and urbanicity, which both have been related to schizophrenia. Meta-analyses show an association with urban environment after controlling for minority status (van Os et al., 2010). Individuals living in a higher degree of urbanization had a higher risk to develop schizophrenia than people living in rural areas with a dose-dependent relationship (Pedersen and Mortensen, 2001). In healthy controls, city living was associated with increased amygdala activity, whereas urban upbringing affected the anterior cingulate cortex, affective, and stress response (Lederbogen et al., 2011). In first- and second-generation migrants as well as in minority groups across all cultures, psychotic symptoms have been shown to be increased (Rapoport et al., 2012). According to the “social defeat hypothesis” it has been assumed that social status and degree, e.g., occupying a minority position or experiencing social exclusion, promotes the development of schizophrenia (van Os et al., 2010).
Maltreated children suffer more likely from severe psychiatric disorders such as major depression, bipolar disorder, post-traumatic stress disorder, anxiety disorders, substance abuse and schizophrenia. Childhood maltreatment has been associated with reduced hippocampal volume and amygdala hyperreactivity and also predicts poor treatment outcome (Teicher and Samson, 2013). To date, apart from a genetic vulnerability, stress is widely accepted as risk factor for depression. The stress sensitization hypothesis describes that the first episode of depression sensitizes an individual to stress for which reason subsequent episodes require less stress to be triggered (Shapero et al., 2014). In extension of this hypothesis, early adverse childhood experiences including emotional abuse, physical, and sexual abuse or neglect have been shown to predict depressive symptoms in adulthood (Shapero et al., 2014). Indicating a gene-environment interaction, genetic factors such as polymorphisms in the serotonin transporter or methylenetetrahydrofolate reductase have been reported to interact with developmental stress to increase the risk for depression (Karg et al., 2011; Lok et al., 2013). However, individual genetic background influences the incidence of depression in response to stress and only a part of the persons experiencing stressors develops depression (Keers and Uher, 2012). Moreover, childhood abuse is known to induce psychotic symptoms and suicidal behavior in patients with major depression and bipolar disorder (Arseneault et al., 2011; Tunnard et al., 2014). Early psychotic symptoms represent a risk for developing schizophrenia. In a meta-analysis of 18 case-control studies, Varese et al. (2012) filtered adverse experiences in childhood to significantly increase the risk to develop psychosis and schizophrenia. The neurobiological consequence of stress sensitization involves dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis, contributing to dopamine sensitization in mesolimbic areas and increased stress-induced striatal dopamine release (van Winkel et al., 2008).
The major stress system of the body is the HPA axis, a neuroendocrine system involved in the production of the stress hormone cortisol by adrenal glands. In a subset of patients with major depression, but also in patients with severe psychiatric disorder across phenotypic diagnosis, a dysfunction of the HPA axis has been detected (MacKenzie et al., 2007; Kapur et al., 2012). Depressed patients with a history of childhood abuse have enhanced HPA axis response to psychosocial stress and attenuated cortisol response to application of the synthetic corticosteroid dexamethasone (Heim et al., 2000). In animal models, acute or chronic stress decreased BDNF levels in the hippocampus inclusive the dentate gyrus (Neto et al., 2011). Along with this hypothesis, stress is known to reduce hippocampal dendrites (Magarinos et al., 2011). It additionally increases plasma and adrenal corticosterone levels and application of this hormone reduced hippocampal BDNF levels, mimicking stress reaction (Neto et al., 2011). Chronic stress or repeated administration of glucocorticoids results in degeneration of hippocampal neurons with decreased soma size and atrophy of dendrites (Sapolsky et al., 1990; Watanabe et al., 1992). Thus, volume loss in vulnerable brain regions like the hippocampus as reported for affective disorders may indeed be mediated by stress-induced glucocorticoid neurotoxicity (Arango et al., 2001; Frodl and O'Keane, 2013). In an animal model of depression, the learned helplessness paradigm, inescapable stress induces downregulation of stem cell proliferation (neurogenesis) in the dentate gyrus of the hippocampus (Malberg and Duman, 2003). Stress is additionally known to influence synaptic plasticity in the prefrontal cortex (Rajkowska, 2000). Mediating gene-environmental interactions, epigenetic mechanisms altering chromatin structure such as histone acetylation and DNA methylation may link effects of environmental factors such as stress to transcriptional regulation of specific genes. Depression-like behavior and antidepressant action have been found to be regulated by epigenetic mechanisms (Sun et al., 2013). For example, stress is known to increase histone methylation at the corresponding promoters of the BDNF gene.
Maternal stress during the prenatal period has been related to schizophrenia, depression, and anxiety (Markham and Koenig, 2011), which also applies to autism spectrum disorder and attention deficit hyperactivity disorder (Class et al., 2014). It includes maternal psychological stress exposure e.g., due to bereavement, unwantedness of a pregnancy, natural disaster or war experience (Brown, 2002; Spauwen et al., 2004; Sullivan, 2005; Meli et al., 2012). Children of mothers who experienced e.g., death of relatives or other serious life events developed schizophrenia to a higher degree (Khashan et al., 2008). War experience e.g., during world war II or Israel's Six-Day-War has also been regarded as a critical factor (van Os and Selten, 1998; Malaspina et al., 2008). Especially during the first or second trimester of pregnancy, a vulnerable brain development period may exist for those stress factors. Beside schizophrenia, depression, and anxiety are consequences of exposure to gestational stress (Torrey et al., 1996; Watson et al., 1999; Brown et al., 2000). Prenatal stress is known to influence function of the HPA axis and secretion of glucocorticoid hormones as well protective capacity of the placenta (Owen et al., 2005; Weinstock, 2005, 2008). In addition to effects on stress hormones, prenatal stress influences the fetal transcriptome through microRNA (miRNA) regulation as an epigenetic mechanism, which links environmental factors to altered gene expression in the pathophysiology of schizophrenia and bipolar disorder (Zucchi et al., 2013). Among 435 miRNAs, 19% exhibited reduced expression in the prefrontal cortex in schizophrenia, or more pronounced in bipolar disorder (Moreau et al., 2011). While 18 miRNAs have been found to be differentially expressed, the miRNA miR-497 and miR-29c have been validated to be overexpressed in exosomes of the prefrontal cortex of patients with schizophrenia or bipolar disorder (Banigan et al., 2013). Moreover, methylation or hydroxymethylation of specific genes or promotors regulates gene expression (Akbarian, 2010). Hypermethylation of sex-determining region Y-box 10 (SOX10) has been reported in schizophrenia, whereas in bipolar disorder hypomethylation of HLA complex group 9 (HCG9), ST6 (alpha-N-acetyl-neuranminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase (ST6GALNAC), and hypermethylation of the serotonin transporter SLCA4 and proline rich membrane anchor 1 (PRIMA1) has been observed (Kato and Iwamoto, 2014). In the frontal cortex of schizophrenia patients, genome-wide methylation analysis revealed differential methylation of 817 genes in promotor regions, among them genes which previously have been associated with schizophrenia (Wockner et al., 2014). Histone modification of chromatin is another epigenetic mechanism to influence gene expression (Peter and Akbarian, 2011). In schizophrenia, altered histone methyltransferases have been detected in the parietal cortex and represent potential future targets for novel treatment strategies (Chase et al., 2013). After prenatal stress in mice, abnormalities in DNA methylation have been described in GABAergic neurons and been related to a schizophrenia-like behavioral phenotype (Matrisciano et al., 2013).
Altered expressions of glucocorticoid receptors and corticotropin-releasing hormone (CRH) in the hippocampus and amygdala have been reported to result from prenatal stress and may be related to increased anxiety and depression-related behavior (Markham and Koenig, 2011). Cognitive deficits of working memory, spatial memory and novel object recognition, related to dysfunctions of the hippocampus and prefrontal cortex, have repeatedly been associated with prenatal stress in animal models and implicate its relationship to severe psychiatric disorders (Markham and Koenig, 2011). Other behavioral consequences are increased locomotor activity and deficits in prepulse inhibition of acoustic startle response (PPI) (Koenig et al., 2005). Increased subcortical and decreased prefrontal dopamine activity after prenatal stress interestingly corresponds to neurotransmitter hypotheses of schizophrenia (Carboni et al., 2010). As a correlate of negative symptoms, social interaction has been reported to be decreased in animals with experience of prenatal stress (Lee et al., 2007). Investigating gene-environmental interaction, a social deficit has been revealed in SNAP-25 knockout mice, which represents a synaptic protein involved in neurotransmitter release, combined with prenatal stress paradigm (Oliver and Davies, 2009).
Some retrospective studies investigated consequences of prenatal food starvation during the “Dutch hunger winter 1944–1945” (Susser et al., 1996; Hoek et al., 1998) and Chinese famine during 1959–1961 (St Clair et al., 2005; Xu et al., 2009). In these investigations, famine episodes of mothers were related to increased risk for schizophrenia in the offspring. Exposure to famine has also been associated with mood disorders and antisocial behavior (Lumey et al., 2011) However, these data are based on ecological inquiries and other factors such as prenatal stress, inflammation, obstetric complications, and toxic substances are not controlled for. Despite these limitations, animal studies revealed effects for protein restriction, choline and vitamin D deficiency on dopamine-related behavior such as locomotor activity and sensorimotor gating, cognition and anxiety, or depression-related behaviors (Markham and Koenig, 2011).
Birth and Obstetric Complications
Several meta-analyses have shown an association between complications of pregnancy and delivery and schizophrenia. This applies to obstetric complications of preeclampsia, bleeding, rhesus incompatibility and diabetes, asphyxia, uterine atony, emergency Ceasarian section, and fetal abnormalities such as low birth weight, congenital malformations, and small head circumference. Effect sizes have been estimated between two and three with the highest effect showing emergency Caesarian section, placental abruption, and low birth weight (Cannon et al., 2002a). Schizophrenia has been associated with boys which were small for gestational age at birth (odds ratio 3.2) (Hultman et al., 1999). Children who experienced fetal hypoxia and later developed schizophrenia or affective disorders had basically lower birth weights, indicating that birth weight is a general marker of viability of the intrauterine environment (Fineberg et al., 2013). An odds ratio of 2.0 has been detected by a meta-analysis of Geddes and Lawrie (1995). The same group investigated another meta-analysis of different obstetric complications and found associations between schizophrenia and use of incubator, prematurity and premature rupture of membranes, while low birthweight and use of forceps during delivery were less consistently related to the disorder (Geddes et al., 1999). Maternal bleeding during pregnancy has been found to be associated with schizophrenia with an odds ratio of 3.5 (Hultman et al., 1999). Interestingly, in individuals at high risk for psychosis, those who de facto converted into psychosis had more obstetric complications than non-converting individuals (Mittal et al., 2009). A common factor of all these complications is perinatal hypoxia (Zornberg et al., 2000), which in rats induced a deficit in prepulse inhibition of acoustic startle response (PPI) in adulthood. This behavioral correlate to schizophrenia responded to treatment with the atypical antipsychotic clozapine (Schmitt et al., 2007; Fendt et al., 2008).
The PPI paradigm reflects function of a specific network of brain regions, among them the hippocampus, prefrontal cortex, striatum, and nucleus accumbens (Swerdlow et al., 2001). Especially the hippocampus and basal ganglia are vulnerable to hypoxia-ischemia in the neonate (Morales et al., 2011). Bilateral hippocampal atrophy has been detected in adolescents with a history of perinatal asphyxia diagnosed as hypoxic-ischemic encephalopathy, along with worse verbal long-term memory (Maneru et al., 2003). In schizophrenia, patients with obstetric complications have shown reduced hippocampal volumes (McNeil et al., 2000; Van Erp et al., 2002; Schulze et al., 2003; Ebner et al., 2008), while no effects have been observed in volumes of basal ganglia (Haukvik et al., 2010). However, effects of antipsychotic medication have to be taken into consideration when investigating brain regions (Lieberman et al., 2005). In patients, fetal hypoxia has been related to increased ventricular size and reduced cortical gray matter (McNeil et al., 2000; Cannon et al., 2002b; Falkai et al., 2003), but results are not consistent (Haukvik et al., 2009). Assessment of the two-dimensional gyrification index (GI) revealed no relationship between obstetric complications and cortical folding (Falkai et al., 2007), but after application of a three-dimensional local GI calculation cortical gyrification has been observed to be reduced in the Broca's area in patients and healthy controls with obstetric complication (Haukvik et al., 2012). Since early stages of gyrification take place during gestational week 16 with a rapid increase in the third trimester (Armstrong et al., 1995), this possibly reflects neurodevelopmental disturbances.
In a meta-analysis of 22 studies, the pooled odds ratio for exposure to obstetric complications and subsequent development of bipolar disorder was 1.01 and for development of major depression 0.61, not supporting the association with affective disorder (Scott et al., 2006). However, in a national register study of 1.3 million Swedes, preterm birth has been significantly associated with affective disorders: those with less than 32 weeks gestation had a 2.9-fold higher risk to develop major depression and 7.4% more likely to have bipolar disorder (Nosarti et al., 2012). In a structural MRI study of 79 patients with bipolar disorder and 140 healthy controls from a Norwegion registry, perinatal asphyxia including a hypoxic state lead to smaller amygdala volumes in the bipolar group with perinatal asphyxia, while the non-psychotic group had an association with smaller hippocampal volumes (Haukvik et al., 2013). This is important for the pathophysiology of bipolar disorder, since meta-analyses have revealed smaller amygdala and hippocampus volumes in lithium-naïve patients with bipolar disorder (Hallahan et al., 2011; Hajek et al., 2012).
The consequences of fetal hypoxia comprise neuronal death, white matter damage with impaired myelination and reduced growth of dendrites with more profound effects at mid than late gestation (Rees et al., 2008). Apart from axonal degeneration, especially oligodendrocytes and periventricular white matter are sensible for the influence of oxygen restriction (Kaur et al., 2006). Additionally, an excess of glutamate via hypofunction of the N-methyl-D-aspartate (NMDA) receptor, which has been proposed to play a major role in the pathophysiology of schizophrenia (Hashimoto et al., 2013; Weickert et al., 2013), may damage oligodendroglia and myelin and influence oligodendrocyte differentiation (Mitterauer and Kofler-Westergren, 2011; Cavaliere et al., 2013). Thereby, contributing to cognitive deficits, increased glutamate levels may induce a synaptic imbalance between axons and oligodendroglia, affecting the glial network (syncytium) which is composed of oligodendrocytes and astrocytes (Mitterauer, 2011). In schizophrenia, decreased oligodendrocyte number has been detected in CA4 of the hippocampus and prefrontal cortex (Hof et al., 2003; Schmitt et al., 2009). Although no astrocytosis has been found in schizophrenia (Schmitt et al., 2009), dysfunction of astrocytes may be present in psychiatric disorders (Mitterauer, 2011). At the paranodal junctions between axons and terminal loops of oligodendrocytes, contactin-associated protein is expressed and has been reported to be downregulated in schizophrenia, thus modulating glia-neuronal interaction (Schmitt et al., 2012). In addition to these glial networks, microglia is known to be activated by hypoxic periods and may mediate cell damage via production of nitric oxide synthase, linking neonatal hypoxia to inflammatory processes (Kaur et al., 2006). In the rat model of perinatal hypoxia, cDNA microarray derived analysis revealed synaptic genes like complexin 1, syntaxin 1A, SNAP 25, neuropeptide Y, and neurexin 1 to be deregulated in several cortical regions and striatum during adulthood. In this study, clozapine treatment had effects on gene expression (Sommer et al., 2010). These findings are relevant to schizophrenia, which has been described as a disease of dysconnectivity on the synaptic and systematic level (Schmitt et al., 2011a, 2012).
Inflammation During Pregnancy
As to offspring of mothers exposed to influenza, several epidemiological studies have demonstrated an increased risk for schizophrenia. However, infections with other viruses such as measles, rubella, varicella-zoster, polio, and herpes as well as bacteria and parasites (Toxoplasma gondii) also confer an increased risk of schizophrenia (Hagberg et al., 2012). Moreover, maternal infections and subsequent inflammatory processes and brain injury during pregnancy are known to be associated with preterm labor, especially at <30 weeks of gestation (Dammann et al., 2002; Goldenberg et al., 2008). These complications are known to affect white matter structures such as corpus callosum or other major white matter tracts and may be associated with neurodevelopmental injury of oligodendrocytes in schizophrenia (Chew et al., 2013). In fact, decreased numbers of oligodendrocytes have been detected in the hippocampus and prefrontal cortex in post-mortem brains of schizophrenia patients and may affect subsequent myelination (Hof et al., 2002; Schmitt et al., 2009). Pro-inflammatory cytokine release has been described as common mechanism of infectious processes (Brown, 2012; Garbett et al., 2012). In the prefrontal cortex of schizophrenia patients, gene expression analysis revealed increased expression of inflammatory genes along with activation of microglia (Beumer et al., 2012; Fillman et al., 2013), but results in the superior temporal cortex also point to the reduced expression of immune-related genes (Schmitt et al., 2011b). In which manner these post-mortem findings are related to perinatal insults is not yet resolved. In animal studies, maternal infection induced behavioral abnormalities in early adulthood comparable to schizophrenia such as deficits in PPI, social interaction and working memory (Meyer and Feldon, 2009).
Challenging Future Investigations: Gene-Environmental Interaction
Many efforts have been made to unravel the genetic background of severe psychiatric disorders. Recent GWAS point toward a partial overlap in susceptibility between schizophrenia and affective disorders (Cross-Disorder Group of the Psychiatric Genomics Consortium et al., 2013). For example, the risk variant of the alpha 1C subunit of the L-type voltage-gated calcium channel (CACNA1C) gene is associated with schizophrenia, bipolar disorder and major depression (Green et al., 2010). This genotype has been shown to influence hippocampal activation during episodic memory encoding and retrieval (Krug et al., 2013). However, effect sizes for common genetic variants so far were small (Brown, 2011; Réthelyi et al., 2013). Environmental factors, especially those affecting molecular and structural processes in relevant brain regions during neurodevelopment, are supposed to interact with genetic factors to induce severe psychiatric disorders (Harrison and Weinberger, 2005). For example, a large number of schizophrenia candidate genes are known to be regulated by hypoxia (Fatemi and Folsom, 2009; Schmidt-Kastner et al., 2012). In transgenic animal models of schizophrenia, stressful events have been induced to reinforce the behavioral phenotype (Haque et al., 2012; Hida et al., 2013). Future animal studies should combine risk variants of susceptibility genes with several environmental factors such as perinatal infection, stress and hypoxia to develop valid models of severe psychiatric disorders. These models could be useful to understand pathophysiological brain mechanisms and to develop new treatment strategies aiming at risk-based therapy and prevention of symptoms of severe psychiatric disorders.
Conflict of Interest Statement
Berend Malchow declares no conflicts of interest. Alkomiet Hasan has been invited to scientific conferences by Janssen Cilag, Pfizer, and Lundbeck. He received paid speakership by Desitin and is member of the Roche advisory board. Andrea Schmitt was honorary speaker for TAD Pharma and Roche and has been member of the Roche advisory board. Peter Falkai until 12/2011 has been member of the advisory boards of Janssen-Cilag, BMS, Lundback, Pfizer, Lilly, and AstraZeneca and received an educational grant from AstraZeneca and honoraria as lecturer from Janssen-Cilag, BMS, Lundbeck, Pfizer, Lilly, and AstraZeneca.
References
Adriano, F., Caltagirone, C., and Spalletta, G. (2012). Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 18, 180–200. doi: 10.1177/1073858410395147
Akbarian, S. (2010). Epigenetics of schizophrenia. Curr. Top. Behav. Neurosci. 4, 611–628. doi: 10.1007/7854_2010_38
Albus, M., Hubmann, W., Mohr, F., Hecht, S., Hinterberger-Weber, P., Seitz, N. N., et al. (2006). Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study. Eur. Arch. Psychiatry Clin. Neurosci. 256, 442–451. doi: 10.1007/s00406-006-0667-1
Albus, M., Hubmann, W., Scherer, J., Dreikorn, B., Hecht, S., Sobizack, N., et al. (2002). A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 252, 262–267. doi: 10.1007/s00406-002-0391-4
Alsuwaidan, M. T., Kucyi, A., Law, C. W., and McIntyre, R. S. (2009). Exercise and bipolar disorder: a review of neurobiological mediators. Neuromolecular Med. 11, 328–336. doi: 10.1007/s12017-009-8079-9
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
Andreasen, N. C., Arndt, S., Alliger, R., Miller, D., and Flaum, M. (1995). Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry 52, 341–351. doi: 10.1001/archpsyc.1995.03950170015003
Arango, C., Kirkpatrick, B., and Koenig, J. (2001). At issue: stress, hippocampal neuronal turnover, and neuropsychiatric disorders. Schizophr. Bull. 27, 477–480. doi: 10.1093/oxfordjournals.schbul.a006888
Armstrong, E., Schleicher, A., Omran, H., Curtis, M., and Zilles, K. (1995). The ontogeny of human gyrification. Cereb. Cortex 5, 56–63. doi: 10.1093/cercor/5.1.56
Arseneault, L., Cannon, M., Fisher, H. L., Polanczyk, G., Moffitt, T. E., and Caspi, A. (2011). Childhood trauma and children's emerging psychotic symptoms: a genetically sensitive longitudinal cohort study. Am. J. Psychiatry 168, 65–72. doi: 10.1176/appi.ajp.2010.10040567
Banigan, M. G., Kao, P. F., Kozubek, J. A., Winslow, A. R., Medina, J., Costa, J., et al. (2013). Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS ONE 8:e48814. doi: 10.1371/journal.pone.0048814
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., and Mortensen, P. B. (2011). Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am. J. Psychiatry 168, 1303–1310. doi: 10.1176/appi.ajp.2011.11030516
Beumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., et al. (2012). The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 92, 959–975. doi: 10.1189/jlb.0212100
Brown, A. S. (2002). Prenatal risk factors and schizophrenia. Expert Rev. Neurother. 2, 53–60. doi: 10.1586/14737175.2.1.53
Brown, A. S. (2011). The environment and susceptibility to schizophrenia. Prog. Neurobiol. 93, 23–58. doi: 10.1016/j.pneurobio.2010.09.003
Brown, A. S. (2012). Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev. Neurobiol. 72, 1272–1276. doi: 10.1002/dneu.22024
Brown, A. S., van Os, J., Driessens, C., Hoek, H. W., and Susser, E. S. (2000). Further evidence of relation between prenatal famine and major affective disorder. Am. J. Psychiatry 157, 190–195. doi: 10.1176/appi.ajp.157.2.190
Bullmore, E. T., Frangou, S., and Murray, R. M. (1997). The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophr. Res. 28, 143–156. doi: 10.1016/S0920-9964(97)00114-X
Cannon, T. D., Thompson, P. M., van Erp, T. G., Toga, A. W., Poutanen, V. P., Huttunen, M., et al. (2002a). Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 99, 3228–3233. doi: 10.1073/pnas.052023499
Cannon, T. D., van Erp, T. G., Rosso, I. M., Huttunen, M., Lonnqvist, J., Pirkola, T., et al. (2002b). Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry 59, 35–41. doi: 10.1001/archpsyc.59.1.35
Carboni, E., Barros, V. G., Ibba, M., Silvagni, A., Mura, C., and Antonelli, M. C. (2010). Prenatal restraint stress: an in vivo microdialysis study on catecholamine release in the rat prefrontal cortex. Neuroscience 168, 156–166. doi: 10.1016/j.neuroscience.2010.03.046
Cavaliere, F., Benito-Munoz, M., Panicker, M., and Matute, C. (2013). NMDA modulates oligodendrocyte differentiation of subventricular zone cells through PKC activation. Front. Cell. Neurosci. 7:261. doi: 10.3389/fncel.2013.00261
Chase, K. A., Gavin, D. P., Guidotti, A., and Sharma, R. P. (2013). Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia. Schizophr. Res. 149, 15–20. doi: 10.1016/j.schres.2013.06.021
Chew, L. J., Fusar-Poli, P., and Schmitz, T. (2013). Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev. Neurosci. 35, 102–129. doi: 10.1159/000346157
Class, Q. A., Abel, K. M., Khashan, A. S., Rickert, M. E., Dalman, C., Larsson, H., et al. (2014). Offspring psychopathology following preconception, prenatal and postnatal maternal bereavement stress. Psychol Med. 44, 71–84. doi: 10.1017/S0033291713000780
Cole, J., Costafreda, S. G., McGuffin, P., and Fu, C. H. (2011). Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. J. Affect. Disord. 134, 483–487. doi: 10.1016/j.jad.2011.05.057
Cole, J., Toga, A. W., Hojatkashani, C., Thompson, P., Costafreda, S. G., Cleare, A. J., et al. (2010). Subregional hippocampal deformations in major depressive disorder. J. Affect. Disord. 126, 272–277. doi: 10.1016/j.jad.2010.03.004
Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee, S. H., Ripke, S., Neale, B. M., Faraone, S. V., Purcell, S. M., et al. (2013). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984–994. doi: 10.1038/ng.2711
Crow, T. J. (1980). Molecular pathology of schizophrenia: more than one disease process? Br. Med. J. 280, 66–68. doi: 10.1136/bmj.280.6207.66
Dammann, O., Kuban, K. C., and Leviton, A. (2002). Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment. Retard. Dev. Disabil. Res. Rev. 8, 46–50. doi: 10.1002/mrdd.10005
Ebner, F., Tepest, R., Dani, I., Pfeiffer, U., Schulze, T. G., Rietschel, M., et al. (2008). The hippocampus in families with schizophrenia in relation to obstetric complications. Schizophr. Res. 104, 71–78. doi: 10.1016/j.schres.2008.06.007
Falkai, P., Honer, W. G., Kamer, T., Dustert, S., Vogeley, K., Schneider-Axmann, T., et al. (2007). Disturbed frontal gyrification within families affected with schizophrenia. J. Psychiatr. Res. 41, 805–813. doi: 10.1016/j.jpsychires.2006.07.018
Falkai, P., Schmitt, A., and Cannon, T. D. (2011). “Pathophysiology of Schizophrenia,” in Schizophrenia: Current Science and Clinical Practice, ed W. Gaebel (New York, NY: Wiley-Blackwell), 31–65.
Falkai, P., Schneider-Axmann, T., Honer, W. G., Vogeley, K., Schonell, H., Pfeiffer, U., et al. (2003). Influence of genetic loading, obstetric complications and premorbid adjustment on brain morphology in schizophrenia: a MRI study. Eur. Arch. Psychiatry Clin. Neurosci. 253, 92–99. doi: 10.1007/s00406-003-0414-9
Fanselow, M. S. (2000). Contextual fear, gestalt memories, and the hippocampus. Behav. Brain Res. 110, 73–81. doi: 10.1016/S0166-4328(99)00186-2
Fatemi, S. H., and Folsom, T. D. (2009). The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull. 35, 528–548. doi: 10.1093/schbul/sbn187
Fendt, M., Lex, A., Falkai, P., Henn, F. A., and Schmitt, A. (2008). Behavioural alterations in rats following neonatal hypoxia and effects of clozapine: implications for schizophrenia. Pharmacopsychiatry 41, 138–145. doi: 10.1055/s-2008-1058107
Ferreira, M. A., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., et al. (2008). Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 40, 1056–1058. doi: 10.1038/ng.209
Fillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., et al. (2013). Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 18, 206–214. doi: 10.1038/mp.2012.110
Fineberg, A. M., Ellman, L. M., Buka, S., Yolken, R., and Cannon, T. D. (2013). Decreased birth weight in psychosis: influence of prenatal exposure to serologically determined influenza and hypoxia. Schizophr. Bull. 39, 1037–1044. doi: 10.1093/schbul/sbs084
Frodl, T., and O'Keane, V. (2013). How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol. Dis. 52, 24–37. doi: 10.1016/j.nbd.2012.03.012
Gaebel, W., Falkai, P., Weinmann, S., and Wobrock, T. (2006). S3 Behandlungsleitlinie Schizophrenie. Darmstadt: Springer.
Garbett, K. A., Hsiao, E. Y., Kalman, S., Patterson, P. H., and Mirnics, K. (2012). Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl. Psychiatry 2:e98. doi: 10.1038/tp.2012.24
Geddes, J. R., and Lawrie, S. M. (1995). Obstetric complications and schizophrenia: a meta-analysis. Br. J. Psychiatry 167, 786–793. doi: 10.1192/bjp.167.6.786
Geddes, J. R., Verdoux, H., Takei, N., Lawrie, S. M., Bovet, P., Eagles, J. M., et al. (1999). Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr. Bull. 25, 413–423. doi: 10.1093/oxfordjournals.schbul.a033389
Goldenberg, R. L., Culhane, J. F., Iams, J. D., and Romero, R. (2008). Epidemiology and causes of preterm birth. Lancet 371, 75–84. doi: 10.1016/S0140-6736(08)60074-4
Green, E. K., Grozeva, D., Jones, I., Jones, L., Kirov, G., Caesar, S., et al. (2010). The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 15, 1016–1022. doi: 10.1038/mp.2009.49
Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321–330.
Hagberg, H., Gressens, P., and Mallard, C. (2012). Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann. Neurol. 71, 444–457. doi: 10.1002/ana.22620
Hajek, T., Kopecek, M., Hoschl, C., and Alda, M. (2012). Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J. Psychiatry Neurosci. 37, 333–343. doi: 10.1503/jpn.110143
Hallahan, B., Newell, J., Soares, J. C., Brambilla, P., Strakowski, S. M., Fleck, D. E., et al. (2011). Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol. Psychiatry 69, 326–335. doi: 10.1016/j.biopsych.2010.08.029
Haque, F. N., Lipina, T. V., Roder, J. C., and Wong, A. H. (2012). Social defeat interacts with Disc1 mutations in the mouse to affect behavior. Behav. Brain Res. 233, 337–344. doi: 10.1016/j.bbr.2012.05.037
Harrison, P. J., and Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40–68; image 5. doi: 10.1038/sj.mp.4001558
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., et al. (2012). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J. Biol. Psychiatry 13, 318–378. doi: 10.3109/15622975.2012.696143
Hashimoto, K., Malchow, B., Falkai, P., and Schmitt, A. (2013). Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur. Arch. Psychiatry Clin, Neurosci. 263, 367–377. doi: 10.1007/s00406-013-0399-y
Haukvik, U. K., Lawyer, G., Bjerkan, P. S., Hartberg, C. B., Jonsson, E. G., McNeil, T., et al. (2009). Cerebral cortical thickness and a history of obstetric complications in schizophrenia. J. Psychiatr. Res. 43, 1287–1293. doi: 10.1016/j.jpsychires.2009.05.001
Haukvik, U. K, McNeil, T., Lange, E. H., Melle, I., Dale, A. M., Andreassen, O. A., et al. (2013). Pre- and perinatal hypoxia associated with hippocampus/amygdala volume in bipolar disorder. Psychol. Med. 1–11. doi: 10.1017/S0033291713001529. [Epub ahead of print].
Haukvik, U. K., McNeil, T., Nesvag, R., Soderman, E., Jonsson, E., and Agartz, I. (2010). No effect of obstetric complications on basal ganglia volumes in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 619–623. doi: 10.1016/j.pnpbp.2010.02.024
Haukvik, U. K., Schaer, M., Nesvag, R., McNeil, T., Hartberg, C. B., Jonsson, E. G., et al. (2012). Cortical folding in Broca's area relates to obstetric complications in schizophrenia patients and healthy controls. Psychol. Med. 42, 1329–1337. doi: 10.1017/S0033291711002315
Heim, C., Newport, D. J., Heit, S., Graham, Y. P., Wilcox, M., Bonsall, R., et al. (2000). Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284, 592–597. doi: 10.1001/jama.284.5.592
Heinrichs, R. W., and Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426–445. doi: 10.1037/0894-4105.12.3.426
Hida, H., Mouri, A., and Noda, Y. (2013). Behavioral phenotypes in schizophrenic animal models with multiple combinations of genetic and environmental factors. J. Pharmacol. Sci. 121, 185–191. doi: 10.1254/jphs.12R15CP
Hill, S. K., Reilly, J. L., Keefe, R. S., Gold, J. M., Bishop, J. R., Gershon, E. S., et al. (2013). Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am. J. Psychiatry 170, 1275–1284. doi: 10.1176/appi.ajp.2013.12101298
Hoek, H. W., Brown, A. S., and Susser, E. (1998). The Dutch famine and schizophrenia spectrum disorders. Soc. Psychiatry Psychiatr. Epidemiol. 33, 373–379. doi: 10.1007/s001270050068
Hof, P. R., Haroutunian, V., Copland, C., Davis, K. L., and Buxbaum, J. D. (2002). Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem. Res. 27, 1193–1200. doi: 10.1023/A:1020981510759
Hof, P. R., Haroutunian, V., Friedrich, V. L. Jr., Byne, W., Buitron, C., Perl, D. P., et al. (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 53, 1075–1085. doi: 10.1016/S0006-3223(03)00237-3
Hoff, A. L., Harris, D., Faustman, W. O., Beal, M., DeVilliers, D., Mone, R. D., et al. (1996). A neuropsychological study of early onset schizophrenia. Schizophr. Res. 20, 21–28. doi: 10.1016/0920-9964(95)00065-8
Hoff, A. L., Svetina, C., Shields, G., Stewart, J., and DeLisi, L. E. (2005). Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr. Res. 78, 27–34. doi: 10.1016/j.schres.2005.05.010
Hultman, C. M., Sparen, P., Takei, N., Murray, R. M., and Cnattingius, S. (1999). Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ 318, 421–426. doi: 10.1136/bmj.318.7181.421
Kapur, S., Phillips, A. G., and Insel, T. R. (2012). Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol. Psychiatry 17, 1174–1179. doi: 10.1038/mp.2012.105
Karg, K., Burmeister, M., Shedden, K., and Sen, S. (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 68, 444–454. doi: 10.1001/archgenpsychiatry.2010.189
Kato, T., and Iwamoto, K. (2014). Kato T, Iwamoto K. Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders. Neuropharmacology. doi: 10.1016/j.neuropharm.2013.12.019. [Epub ahead of print].
Kaur, C., Sivakumar, V., Ang, L. S., and Sundaresan, A. (2006). Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J. Neurochem. 98, 1200–1216. doi: 10.1111/j.1471-4159.2006.03964.x
Keers, R., and Uher, R. (2012). Gene-environment interaction in major depression and antidepressant treatment response. Curr. Psychiatry Rep. 14, 129–137. doi: 10.1007/s11920-011-0251-x
Kendler, K. S., Gallagher, T. J., Abelson, J. M., and Kessler, R. C. (1996). Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch. Gen. Psychiatry 53, 1022–1031. doi: 10.1001/archpsyc.1996.01830110060007
Keshavan, M. S., and Hogarty, G. E. (1999). Brain maturational processes and delayed onset in schizophrenia. Dev. Psychopathol. 11, 525–543. doi: 10.1017/S0954579499002199
Khashan, A. S., Abel, K. M., McNamee, R., Pedersen, M. G., Webb, R. T., Baker, P. N., et al. (2008). Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch. Gen. Psychiatry 65, 146–152. doi: 10.1001/archgenpsychiatry.2007.20
Koenig, J. I., Elmer, G. I., Shepard, P. D., Lee, P. R., Mayo, C., Joy, B., et al. (2005). Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav. Brain Res. 156, 251–261. doi: 10.1016/j.bbr.2004.05.030
Krug, A., Witt, S. H., Backes, H., Dietsche, B., Nieratschker, V., Shah, N. J., et al. (2013). genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval. Eur. Arch. Psychiatry Clin. Neurosci. doi: 10.1007/s00406-013-0428-x. [Epub ahead of print].
Lederbogen, F., Kirsch, P., Haddad, L., Streit, F., Tost, H., Schuch, P., et al. (2011). City living and urban upbringing affect neural social stress processing in humans. Nature 474, 498–501. doi: 10.1038/nature10190
Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., and Koenig, J. I. (2007). Prenatal stress generates deficits in rat social behavior: reversal by oxytocin. Brain Res. 1156, 152–167. doi: 10.1016/j.brainres.2007.04.042
Lieberman, J. A., Tollefson, G. D., Charles, C., Zipursky, R., Sharma, T., Kahn, R. S., et al. (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62, 361–370. doi: 10.1001/archpsyc.62.4.361
Lipska, B. K. (2004). Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J. Psychiatry Neurosci. 29, 282–286.
Lok, A., Bockting, C. L., Koeter, M. W., Snieder, H., Assies, J., Mocking, R. J., et al. (2013). Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression. Transl. Psychiatry 3:e288. doi: 10.1038/tp.2013.60
Lumey, L. H., Stein, A. D., and Susser, E. (2011). Prenatal famine and adult health. Annu. Rev. Public Health 32, 237–262. doi: 10.1146/annurev-publhealth-031210-101230
MacKenzie, E. M., Odontiadis, J., Le Melledo, J. M., Prior, T. I., and Baker, G. B. (2007). The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell. Mol. Neurobiol. 27, 541–574. doi: 10.1007/s10571-006-9086-0
Magarinos, A. M., Li, C. J., Gal Toth, J., Bath, K. G., Jing, D., Lee, F. S., et al. (2011). Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons. Hippocampus 21, 253–264. doi: 10.1002/hipo.20744
Malaspina, D., Corcoran, C., Kleinhaus, K. R., Perrin, M. C., Fennig, S., Nahon, D., et al. (2008). Acute maternal stress in pregnancy and schizophrenia in offspring: a cohort prospective study. PLoS Psychiatry 8:71. doi: 10.1186/1471-244X-8-71
Malberg, J. E., and Duman, R. S. (2003). Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28, 1562–1571. doi: 10.1038/sj.npp.1300234
Maller, J. J., Daskalakis, Z. J., Thomson, R. H., Daigle, M., Barr, M. S., and Fitzgerald, P. B. (2012). Hippocampal volumetrics in treatment-resistant depression and schizophrenia: the devil's in de-tail. Hippocampus 22, 9–16. doi: 10.1002/hipo.20873
Maneru, C., Serra-Grabulosa, J. M., Junque, C., Salgado-Pineda, P., Bargallo, N., Olondo, M., et al. (2003). Residual hippocampal atrophy in asphyxiated term neonates. J. Neuroimaging 13, 68–74. doi: 10.1177/1051228402239720
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature 461, 747–753. doi: 10.1038/nature08494
Markham, J. A., and Koenig, J. I. (2011). Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology (Berl.) 214, 89–106. doi: 10.1007/s00213-010-2035-0
Matrisciano, F., Tueting, P., Dalal, I., Kadriu, B., Grayson, D. R., Davis, J. M., et al. (2013). Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology 68, 184–194. doi: 10.1016/j.neuropharm.2012.04.013
McEwen, B. S., and Magarinos, A. M. (2001). Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum. Psychopharmacol. 16, S7–S19. doi: 10.1002/hup.266
McGrath, J., Saha, S., Chant, D., and Welham, J. (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 30, 67–76. doi: 10.1093/epirev/mxn001
McNeil, T. F., Cantor-Graae, E., and Weinberger, D. R. (2000). Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am. J. Psychiatry 157, 203–212. doi: 10.1176/appi.ajp.157.2.203
Meisenzahl, E. M., Seifert, D., Bottlender, R., Teipel, S., Zetzsche, T., Jager, M., et al. (2010). Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study. Eur. Arch. Psychiatry Clin. Neurosci. 260, 127–137. doi: 10.1007/s00406-009-0023-3
Meli, G., Ottl, B., Paladini, A., and Cataldi, L. (2012). Prenatal and perinatal risk factors of schizophrenia. J. Matern. Fetal Neonatal Med. 25, 2559–2563. doi: 10.3109/14767058.2012.699118
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M., Petukhova, M., et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch. Gen. Psychiatry 64, 543–552. doi: 10.1001/archpsyc.64.5.543
Meyer, T. D., and Hautzinger, M. (2003). The structure of affective symptoms in a sample of young adults. Compr. Psychiatry 44, 110–116. doi: 10.1053/comp.2003.50025
Meyer, U., and Feldon, J. (2009). Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav. Brain Res. 204, 322–334. doi: 10.1016/j.bbr.2008.12.022
Mittal, V. A., Willhite, R., Daley, M., Bearden, C. E., Niendam, T., Ellman, L. M., et al. (2009). Obstetric complications and risk for conversion to psychosis among individuals at high clinical risk. Early Interv. Psychiatry 3, 226–230. doi: 10.1111/j.1751-7893.2009.00137.x
Mitterauer, B. J. (2011). Possible role of glia in cognitive impairment in schizophrenia. CNS Neurosci. Ther. 17, 333–344. doi: 10.1111/j.1755-5949.2009.00113.x
Mitterauer, B. J., and Kofler-Westergren, B. (2011). Possible effects of synaptic imbalances on oligodendrocyte-axonic interactions in schizophrenia: a hypothetical model. Front. Psychiatry 2:15. doi: 10.3389/fpsyt.2011.00015
Morales, P., Bustamante, D., Espina-Marchant, P., Neira-Pena, T., Gutierrez-Hernandez, M. A., Allende-Castro, C., et al. (2011). Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes? EPMA J. 2, 211–230. doi: 10.1007/s13167-011-0100-3
Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., and Brzustowicz, L. M. (2011). Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 69, 188–193. doi: 10.1016/j.biopsych.2010.09.039
Neto, F. L., Borges, G., Torres-Sanchez, S., Mico, J. A., and Berrocoso, E. (2011). Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr. Neuropharmacol. 9, 530–552. doi: 10.2174/157015911798376262
Nosarti, C., Reichenberg, A., Murray, R. M., Cnattingius, S., Lambe, M. P., Yin, L., et al. (2012). Preterm birth and psychiatric disorders in young adult life. Arch. Gen. Psychiatry 69, E1–E8. doi: 10.1001/archgenpsychiatry.2011.1374
Oliver, P. L., and Davies, K. E. (2009). Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Hum. Mol. Genet. 18, 4576–4589. doi: 10.1093/hmg/ddp425
Owen, D., Andrews, M. H., and Matthews, S. G. (2005). Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci. Biobehav. Rev. 29, 209–226. doi: 10.1016/j.neubiorev.2004.10.004
Pedersen, C. B., and Mortensen, P. B. (2001). Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch. Gen. Psychiatry 58, 1039–1046. doi: 10.1001/archpsyc.58.11.1039
Peter, C. J., and Akbarian, S. (2011). Balancing histone methylation activities in psychiatric disorders. Trends Mol. Med. 17, 372–379. doi: 10.1016/j.molmed.2011.02.003
Peters, B. D., Szeszko, P. R., Radua, J., Ikuta, T., Gruner, P., DeRosse, P., et al. (2012). White matter development in adolescence: diffusion tensor imaging and meta-analytic results. Schizophr. Bull. 38, 1308–1317. doi: 10.1093/schbul/sbs054
Rajkowska, G. (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48, 766–777. doi: 10.1016/S0006-3223(00)00950-1
Rapoport, J. L., Giedd, J. N., and Gogtay, N. (2012). Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 17, 1228–1238. doi: 10.1038/mp.2012.23
Rees, S., Harding, R., and Walker, D. (2008). An adverse intrauterine environment: implications for injury and altered development of the brain. Int. J. Dev. Neurosci. 26, 3–11. doi: 10.1016/j.ijdevneu.2007.08.020
Réthelyi, J. M., Benkovits, J., and Bitter, I. (2013). Genes and environments in schizophrenia: the different pieces of a manifold puzzle. Neurosci. Biobehav. Rev. 37, 2424–2437. doi: 10.1016/j.neubiorev.2013.04.010
Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J. L., Kahler, A. K., Akterin, S., et al. (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150–1159. doi: 10.1038/ng.2742
Sapolsky, R. M., Uno, H., Rebert, C. S., and Finch, C. E. (1990). Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10, 2897–2902.
Schmidt-Kastner, R., van Os, J., Esquivel, G., Steinbusch, H. W., and Rutten, B. P. (2012). An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol. Psychiatry 17, 1194–1205. doi: 10.1038/mp.2011.183
Schmitt, A., Fendt, M., Zink, M., Ebert, U., Starke, M., Berthold, M., et al. (2007). Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia. J. Neural Transm. 114, 239–248. doi: 10.1007/s00702-006-0440-7
Schmitt, A., Hasan, A., Gruber, O., and Falkai, P. (2011a). Schizophrenia as a disorder of disconnectivity. Eur. Arch. Psychiatry Clin. Neurosci. 261(Suppl 2), S150–S154. doi: 10.1007/s00406-011-0242-2
Schmitt, A., Leonardi-Essmann, F., Durrenberger, P. F., Parlapani, E., Schneider-Axmann, T., Spanagel, R., et al. (2011b). Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study. World J. Biol. Psychiatry 12, 201–215. doi: 10.3109/15622975.2010.530690
Schmitt, A., Leonardi-Essmann, F., Durrenberger, P. F., Wichert, S. P., Spanagel, R., Arzberger, T., et al. (2012). Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients. Eur. Arch. Psychiatry Clin. Neurosci. 262, 565–577. doi: 10.1007/s00406-012-0306-y
Schmitt, A., Steyskal, C., Bernstein, H. G., Schneider-Axmann, T., Parlapani, E., Schaeffer, E. L., et al. (2009). Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol. 117, 395–407. doi: 10.1007/s00401-008-0430-y
Schulze, K., McDonald, C., Frangou, S., Sham, P., Grech, A., Toulopoulou, T., et al. (2003). Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives. Biol. Psychiatry 53, 562–570. doi: 10.1016/S0006-3223(02)01910-8
Schwab, S. G., and Wildenauer, D. B. (2013). Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 263(Suppl. 2), S147–S154. doi: 10.1007/s00406-013-0450-z
Scott, J., McNeill, Y., Cavanagh, J., Cannon, M., and Murray, R. (2006). Exposure to obstetric complications and subsequent development of bipolar disorder: systematic review. Br. J. Psychiatry 189, 3–11. doi: 10.1192/bjp.bp.105.010579
Shapero, B. G., Black, S. K., Liu, R. T., Klugman, J., Bender, R. E., Abramson, L. Y., et al. (2014). Stressful life events and depression symptoms: the effect of childhood emotional abuse on stress reactivity. J. Clin. Psychol. 70, 209–223. doi: 10.1002/jclp.22011
Sommer, J. U., Schmitt, A., Heck, M., Schaeffer, E. L., Fendt, M., Zink, M., et al. (2010). Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 260(Suppl. 2), S81–S89. doi: 10.1007/s00406-010-0159-1
Spauwen, J., Krabbendam, L., Lieb, R., Wittchen, H. U., and van Os, J. (2004). Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta Psychiatr. Scand. 110, 356–364. doi: 10.1111/j.1600-0447.2004.00429.x
St Clair, D., Xu, M., Wang, P., Yu, Y., Fang, Y., Zhang, F., et al. (2005). Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294, 557–562. doi: 10.1001/jama.294.5.557
Steen, R. G., Mull, C., McClure, R., Hamer, R. M., and Lieberman, J. A. (2006). Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188, 510–518. doi: 10.1192/bjp.188.6.510
Sullivan, P. F. (2005). The genetics of schizophrenia. PLoS Med. 2:e212. doi: 10.1371/journal.pmed.0020212
Sullivan, P. F., Kendler, K. S., and Neale, M. C. (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187–1192. doi: 10.1001/archpsyc.60.12.1187
Sun, H., Kennedy, P. J., and Nestler, E. J. (2013). Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 38, 124–137. doi: 10.1038/npp.2012.73
Susser, E., Neugebauer, R., Hoek, H. W., Brown, A. S., Lin, S., Labovitz, D., et al. (1996). Schizophrenia after prenatal famine. Further evidence.Arch. Gen. Psychiatry 53, 25–31. doi: 10.1001/archpsyc.1996.01830010027005
Swerdlow, N. R., Geyer, M. A., and Braff, D. L. (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl). 156, 194–215. doi: 10.1007/s002130100799
Teicher, M. H., and Samson, J. A. (2013). Childhood maltreatment and psychopathology: a case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am. J. Psychiatry 170, 1114–1133. doi: 10.1176/appi.ajp.2013.12070957
Torres, I. J., Boudreau, V. G., and Yatham, L. N. (2007). Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr. Scand. Suppl. 17–26. doi: 10.1111/j.1600-0447.2007.01055.x
Torrey, E. F., Rawlings, R. R., Ennis, J. M., Merrill, D. D., and Flores, D. S. (1996). Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophr. Res. 21, 141–149. doi: 10.1016/0920-9964(96)00022-9
Tunnard, C., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., Fekadu, A., et al. (2014). The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression. J. Affect. Disord. 152–154, 122–130. doi: 10.1016/j.jad.2013.06.037
Van Erp, T. G., Saleh, P. A., Rosso, I. M., Huttunen, M., Lonnqvist, J., Pirkola, T., et al. (2002). Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am. J. Psychiatry 159, 1514–1520. doi: 10.1176/appi.ajp.159.9.1514
van Os, J., Kenis, G., and Rutten, B. P. (2010). The environment and schizophrenia. Nature 468, 203–212. doi: 10.1038/nature09563
van Os, J., and Selten, J. P. (1998). Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Br. J. Psychiatry. 172, 324–326. doi: 10.1192/bjp.172.4.324
van Winkel, R., Stefanis, N. C., and Myin-Germeys, I. (2008). Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull. 34, 1095–1105. doi: 10.1093/schbul/sbn101
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., et al. (2012). Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr. Bull. 38, 661–671. doi: 10.1093/schbul/sbs050
Vita, A., De Peri, L., Silenzi, C., and Dieci, M. (2006). Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr. Res. 82, 75–88. doi: 10.1016/j.schres.2005.11.004
Watanabe, Y., Gould, E., Cameron, H. A., Daniels, D. C., and McEwen, B. S. (1992). Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 2, 431–435. doi: 10.1002/hipo.450020410
Watson, J. B., Mednick, S. A., Huttunen, M., and Wang, X. (1999). Prenatal teratogens and the development of adult mental illness. Dev. Psychopathol. 11, 457–466. doi: 10.1017/S0954579499002151
Weickert, C. S., Fung, S. J., Catts, V. S., Schofield, P. R., Allen, K. M., Moore, L. T., et al. (2013). Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol. Psychiatry 18, 1185–1192. doi: 10.1038/mp.2012.137
Weinberger, D. R. (1996). On the plausibility of “the neurodevelopmental hypothesis” of schizophrenia. Neuropsychopharmacology 14(3 Suppl.), 1S–11S. doi: 10.1016/0893-133X(95)00199-N
Weinstock, M. (2005). The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav. Immun. 19, 296–308. doi: 10.1016/j.bbi.2004.09.006
Weinstock, M. (2008). The long-term behavioural consequences of prenatal stress. Neurosci. Biobehav. Rev. 32, 1073–1086. doi: 10.1016/j.neubiorev.2008.03.002
Williams, D. R., Gonzalez, H. M., Neighbors, H., Nesse, R., Abelson, J. M., Sweetman, J., et al. (2007). Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch. Gen. Psychiatry 64, 305–315. doi: 10.1001/archpsyc.64.3.305
Witthaus, H., Kaufmann, C., Bohner, G., Ozgurdal, S., Gudlowski, Y., Gallinat, J., et al. (2009). Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res. 173, 163–169. doi: 10.1016/j.pscychresns.2008.08.002
Witthaus, H., Mendes, U., Brune, M., Ozgurdal, S., Bohner, G., Gudlowski, Y., et al. (2010). Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J. Psychiatry Neurosci. 35, 33–40. doi: 10.1503/jpn.090013
Wockner, L. F., Noble, E. P., Lawford, B. R., Young, R. M., Morris, C. P., Whitehall, V. L., et al. (2014). Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl. Psychiatry 4:e339. doi: 10.1038/tp.2013.111
Wood, S. J., Kennedy, D., Phillips, L. J., Seal, M. L., Yucel, M., Nelson, B., et al. (2010). Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study. Neuroimage 52, 62–68. doi: 10.1016/j.neuroimage.2010.04.012
Wray, N. R., and Gottesman, I. I. (2012). Using summary data from the danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front. Genet. 3:118. doi: 10.3389/fgene.2012.00118
Xu, M. Q., Sun, W. S., Liu, B. X., Feng, G. Y., Yu, L., Yang, L., et al. (2009). Prenatal malnutrition and adult schizophrenia: further evidence from the 1959-1961 Chinese famine. Schizophr. Bull. 35, 568–576. doi: 10.1093/schbul/sbn168
Yao, L., Lui, S., Liao, Y., Du, M. Y., Hu, N., Thomas, J. A., et al. (2013). White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 45, 100–106. doi: 10.1016/j.pnpbp.2013.04.019
Zornberg, G. L., Buka, S. L., and Tsuang, M. T. (2000). Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am. J. Psychiatry 157, 196–202. doi: 10.1176/appi.ajp.157.2.196
Keywords: schizophrenia, affective disorders, environmental factors, neurodevelopment, obstetric complications, animal models, epigenetics
Citation: Schmitt A, Malchow B, Hasan A and Falkai P (2014) The impact of environmental factors in severe psychiatric disorders. Front. Neurosci. 8:19. doi: 10.3389/fnins.2014.00019
Received: 19 November 2013; Accepted: 23 January 2014;
Published online: 11 February 2014.
Edited by:
Peter J. Gebicke-Haerter, University of Heidelberg, GermanyReviewed by:
Bernhard J. Mitterauer, Volitronics-Institute for Basic Research Psychopathology and Brain Philosophy, AustriaTianxiao Huan, Framingham Heart Study, USA
Copyright © 2014 Schmitt, Malchow, Hasan and Falkai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Andrea Schmitt, Department of Psychiatry and Psychotherapy, LMU Munich, Nußbaumstraße 7, 80336 München, Germany e-mail: andrea.schmitt@med.uni-muenchen.de